3 completed, 3 terminated, 1 recruiting, 1 unknown. 9 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 3, Terminated 3, Recruiting 1, Unknown 1, Withdrawn 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Lung Transplant Rejection: new trials by email Literature Review of Lung Transplant Rejection trials Research Report on Lung Transplant Rejection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HP 129Xe MRI for Evaluation of CLAD in Lung Transplant Recipients 129Xenon - Lung Transplant Rejection | Phase 2 | Terminated | The Hospital for Sick Children | 6 | 2024-02-07 | 2025-09-04 |
| An Open Label Trial Evaluating the Safety, Tolerability, Efficacy and Pharmacokinetic Profile of Tacrolimus Inhalation Powder in Adult Lung Transplant Recipients Tacrolimus Inhalation Powder, Plastiape RS00 Dry Powder inhaler device - Lung Transplant Rejection | Phase 2 | Terminated | TFF Pharmaceuticals, Inc. | 14 | 2023-04-18 | 2025-01-06 |
| Adipose Derived Mesenchymal Cell Treatment in Lungtransplantation adipose derived mesenchymal stromal cells, Saline - Lung Transplant Rejection | Phase 1 / Phase 2 | Unknown | Copenhagen University Hospital, Rigshospitalet | 30 | 2020-10-01 | 2021-07-16 |
| Belatacept Pilot Study in Lung Transplantation Immunosuppression in Lung Transplantation Belatacept, Tacrolimus, ATG - Lung Transplant Rejection, Antibody-mediated Rejection | Phase 2 | Completed | Washington University School of Medicine | 27 | 2019-12-17 | 2022-11-25 |
| Lung Transplant Plasmapheresis/Belatacept/Carfilzomib for Antibody Mediated Rejection and Desensitization Belatacept, Carfilzomib - Lung Transplant Rejection, Antibody-mediated Rejection | Phase 2 | Withdrawn | Duke University | 2019-05-01 | 2019-05-02 | |
| Developing Hyperpolarized Gas MRI Signatures to Detect and Manage Acute Cellular Rejection Sub study (Active): Two Lung MRI study with two navigational Bronchoscopy, Hyperpolarized Xenon129 - Lung Transplant Rejection | Phase 2 | Recruiting | University of Virginia | 60 | 2019-04-01 | 2026-03-17 |
| Pirfenidone for Restrictive Chronic Lung Allograft Dysfunction Pirfenidone - Restrictive Chronic Lung Allograft Dysfunction, Lung Transplant Rejection | Phase 2 | Completed | University of California, San Francisco | 10 | 2018-03-07 | 2023-06-29 |
| Combination Therapy With Carfilzomib for the Antibody-Mediated Rejection Diagnosis in Lung Transplantation Carfilzomib - Lung Transplant Rejection | Phase 2 | Completed | John F. McDyer, MD | 22 | 2015-11-01 | 2022-04-25 |
| Prospective Study for Transplant Optimization Using Functional Imaging (TROFI) HRCT scans - Bronchiolitis Obliterans, Lung Transplant Rejection | Phase 2 | Terminated | FLUIDDA nv | 10 | 2015-07-01 | 2018-03-21 |
Bronchiolitis Obliterans (1) · Bronchiolitis Obliterans Syndrome (1) · Rejection, Psychology (1)
Behavior (1) · Bronchial Diseases (1) · Bronchiolitis (1) · Bronchitis (1) · Graft vs Host Disease (1) · Immune System Diseases (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1) · Organizing Pneumonia (1) · Respiratory Tract Diseases (1) · Social Behavior (1)
Abatacept (2) · Tacrolimus (2) · carfilzomib (2) · Methylprednisolone (1) · Methylprednisolone Hemisuccinate (1) · Mycophenolic Acid (1) · Prednisone (1) · Sodium Chloride (1) · pirfenidone (1) · thymoglobulin (1)
Copenhagen University Hospital, Rigshospitalet (1) · Duke University (1) · FLUIDDA nv (1) · John F. McDyer, MD (1) · TFF Pharmaceuticals, Inc. (1) · The Hospital for Sick Children (1) · University of California, San Francisco (1) · University of Virginia (1) · Washington University School of Medicine (1)
United States (4) · Australia (1) · Belgium (1) · Canada (1) · Denmark (1)
Aida A Venado Estrada, MD (1) · Giles Santyr, PhD (1) · Jens Kastrup, MD Professor (1) · John McDyer, MD (1) · Laurie Snyder (1) · Michael Perch, MD (1) · Ramsey R Hachem, MD (1) · Wilfried De Backer, M.D., M.S. (1) · Yun M Shim, MD (1) · Zamaneh Mikhak, MD (1)
R01HL173369 (1)